Story perspectives
Sichuan Neautus Targets Global Investors with IPO Launch
1/8/2026
1 of 1
Story summary
- Sichuan Neautus Traditional Chinese Medicine filed its IPO application in October and aims to use Hong Kong as a hub for capital and international transactions to attract international investors.
- The firm operates in ten overseas markets, including the United States and Germany, with foreign capital at 30% of its funding.
- Herb Standard plans to use IPO proceeds to expand production capacity and develop an international sales network.
